Cancer researchers are generating mounds of molecular data on tumor biology. Scientists with molecular and computational backgrounds are needed to move the growing field of precision oncology forward. Researchers with both skill sets, however, have a leg up.
When William Pao was a medical oncology fellow at Memorial Sloan Kettering Cancer Center (MSKCC) during the early 2000s, treating patients with metastatic non-small cell lung cancer (NSCLC) was rote: Every patient received the same chemotherapy regimen.
